Aquestive Therapeutics Statistics
Total Valuation
AQST has a market cap or net worth of $220.31 million. The enterprise value is $240.25 million.
| Market Cap | 220.31M |
| Enterprise Value | 240.25M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AQST has 91.04 million shares outstanding. The number of shares has decreased by -0.24% in one year.
| Shares Outstanding | 91.04M |
| Shares Change (YoY) | -0.24% |
| Shares Change (QoQ) | +21.71% |
| Owned by Insiders (%) | 5.03% |
| Owned by Institutions (%) | 46.51% |
| Float | 79.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.28 |
| Forward PS | 4.23 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.28
| Current Ratio | 6.28 |
| Quick Ratio | 5.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.90% |
| Return on Capital (ROIC) | -24.68% |
| Revenue Per Employee | $381,496 |
| Profits Per Employee | -$213,081 |
| Employee Count | 135 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.78 |
Taxes
In the past 12 months, AQST has paid $245,000 in taxes.
| Income Tax | 245,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.31% in the last 52 weeks. The beta is 2.80, so AQST's price volatility has been higher than the market average.
| Beta (5Y) | 2.80 |
| 52-Week Price Change | +50.31% |
| 50-Day Moving Average | 3.08 |
| 200-Day Moving Average | 2.73 |
| Relative Strength Index (RSI) | 35.76 |
| Average Volume (20 Days) | 1,885,544 |
Short Selling Information
The latest short interest is 7.18 million, so 7.89% of the outstanding shares have been sold short.
| Short Interest | 7.18M |
| Short Previous Month | 6.70M |
| Short % of Shares Out | 7.89% |
| Short % of Float | 8.99% |
| Short Ratio (days to cover) | 7.23 |
Income Statement
In the last 12 months, AQST had revenue of $51.50 million and -$28.77 million in losses. Loss per share was -$0.43.
| Revenue | 51.50M |
| Gross Profit | 31.02M |
| Operating Income | -19.45M |
| Pretax Income | -28.52M |
| Net Income | -28.77M |
| EBITDA | -17.12M |
| EBIT | -18.35M |
| Loss Per Share | -$0.43 |
Balance Sheet
The company has $95.20 million in cash and $115.14 million in debt, giving a net cash position of -$19.94 million or -$0.22 per share.
| Cash & Cash Equivalents | 95.20M |
| Total Debt | 115.14M |
| Net Cash | -19.94M |
| Net Cash Per Share | -$0.22 |
| Equity (Book Value) | -36.30M |
| Book Value Per Share | -0.40 |
| Working Capital | 95.32M |
Cash Flow
In the last 12 months, operating cash flow was -$25.58 million and capital expenditures -$1.02 million, giving a free cash flow of -$26.60 million.
| Operating Cash Flow | -25.58M |
| Capital Expenditures | -1.02M |
| Free Cash Flow | -26.60M |
| FCF Per Share | -$0.36 |
Margins
Gross margin is 60.23%, with operating and profit margins of -37.77% and -55.85%.
| Gross Margin | 60.23% |
| Operating Margin | -37.77% |
| Pretax Margin | -55.38% |
| Profit Margin | -55.85% |
| EBITDA Margin | -33.24% |
| EBIT Margin | -35.62% |
| FCF Margin | -51.65% |
Dividends & Yields
AQST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.24% |
| Shareholder Yield | 0.24% |
| Earnings Yield | -13.06% |
| FCF Yield | -12.07% |
Analyst Forecast
The average price target for AQST is $8.71, which is 259.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.71 |
| Price Target Difference | 259.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 31.97% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AQST has an Altman Z-Score of -1.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.98 |
| Piotroski F-Score | 3 |